What transpired at the inaugural GP-Pharmacists Symposium?

PSA's inaugural GP Pharmacists Symposium underscored the expanding scope of the profession – and the policy gaps that still need closing.

Medicinal cannabis: Patient access and clinical evidence

In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...

Sunscreen reassurance on nanotoxicity fears

Nanoparticles contained in sunscreen do not penetrate the skin or cause cellular toxicity, a new Australian study published in the Journal of Investigative Dermatology...

Probiotics for ‘chemo brain’

Affordable and convenient probiotics may help prevent cancer-related cognitive impairment.

Opioid therapy challenges in rural Australia

For more than a decade, healthcare workers in rural and remote areas have been aware of the rising incidence of non-prescribed opioid medicines use....

Meningococcal vaccines

Meningococcal disease is an acute bacterial infection that can affect the brain and spinal cord (meningitis), or the blood (septicaemia); whilst some patients can...